Iliac Stent Market-By Type
Iliac Stent Market-By Artery Lesions
Iliac Stent Market-By End-Use
Iliac Stent Market-By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Iliac Stents Market Snapshot
Chapter 4. Global Iliac Stents Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Self-expandable Stents
5.2.2. Balloon-expandable Stents
5.2.3. Others
Chapter 6. Market Segmentation 2: by Artery Lesions Estimates & Trend Analysis
6.1. by & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Artery Lesions:
6.2.1. Common Iliac Artery Lesions
6.2.2. Severe Calcified Lesions
6.2.3. Complete Obstructive Lesions
Chapter 7. Market Segmentation 3: by End-Use Estimates & Trend Analysis
7.1. by End-Use & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-Use:
7.2.1. Hospitals
7.2.2. Outpatient Facilities
7.2.3. Others
Chapter 8. Iliac Stents Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.1.2. North America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Artery Lesions, 2019-2031
8.1.3. North America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2019-2031
8.1.4. North America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.2.2. Europe Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Artery Lesions, 2019-2031
8.2.3. Europe Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2019-2031
8.2.4. Europe Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.3.2. Asia-Pacific Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Artery Lesions, 2019-2031
8.3.3. Asia Pacific Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2019-2031
8.3.4. Asia Pacific Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.4.2. Latin America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Artery Lesions, 2019-2031
8.4.3. Latin America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2019-2031
8.4.4. Latin America Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.5.2. Middle East & Africa Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by Artery Lesions, 2019-2031
8.5.3. Middle East & Africa Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2019-2031
8.5.4. Middle East & Africa Iliac Stents Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.2. Alvimedica
9.2.3. B. Braun SE
9.2.4. Becton, Dickinson and Company
9.2.5. Biotronik SE & Co KG
9.2.6. Boston Scientific Corporation
9.2.7. Cook Medical
9.2.8. Getinge AB
9.2.9. iVascular
9.2.10. Medtronic Plc
9.2.11. Terumo Corporation
9.2.12. W. L. Gore & Associates, Inc.
9.2.13. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.